MHC control of CD4+ T cell subset activation by unknown
MHC CONTROL OF CD4+ T CELL SUBSET ACTIVATION
By JOSEPH S. MURRAY,' JOSEPH MADRI,tJOHN TITE,
SIMON R. CARDING,' AND KIM BOTTOMLY'
From the 'Section ofImmunobiology and the (Department of Pathology and the
'Howard Hughes Medical Institute at Yale University School ofMedicine,
New Haven, Connecticut 06510
The specific immune response couples recognition of foreign antigens with a va-
riety of effector mechanisms that are broadly classified as either humoral or cell medi-
ated . Humoralimmune responses are mediated by antibody producedby activated
Bcells while cell-mediated responses involvemacrophage andcytolyticTcell activa-
tion . Both forms of immunity require participation of activated CD4' T cells. Re-
cent studies have shown that cloned lines ofCD4* T cells able to elicit effector re-
sponses characteristic ofhumoral or cell mediated immunity are of distinct subsets
(1-3), producing different cytokines (4) that are believed to account for these activi-
ties . Toexamine whetherthe mechanism that determines the effector classof a given
immune response involves normal correlates of cloned CD4' subsets in vivo, we
have studied an immune response in which the effector phenotype is controlled by
aMHC class II gene . We show that different cytokines are produced by CD4' T
cells responding to thesame antigen in mice ofdifferentMHC genotypes. Moreover,
the CD4' T cells responding in mice of different MHC genotypes also differ in their
ability to induce antibody production . These data demonstrate thatMHC class II
genotype can control the -functional outcome of an immune response.
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Materials and Methods
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Mice.
￿
A.SW/Snj andA.BY/Snjmice (female6-8wk old) were purchased fromTheJackson
Laboratory, Bar Harbor, ME .
Antigens.
￿
TypeIVhuman collagen (collagen IV) was purified and characterized as previ-
ously described (5) .
Lymph Node CD4' T Cell Proliferation Assay.
￿
Lymph node cells were isolated from congenic
mice immunized 10 d previously with 50 jug of collagenIV in CFA(H37Ra ; Difco Laborato-
ries, Detroit, MI) at the base of the tail (5) . CD4' T cells were prepared as described (6) .
CD4'T cells were cultured for 96 h at 4 x 105 cells/well with 105 irradiated (3,000 rad) syn-
geneic T-depleted splenic APC/well as described previously (5) .
Hapten-specific IgG Antibody Responses.
￿
2 x 10 5 CD4' T cells were mixed with 106 syngeneic
T cell-depleted spleen cell from TNP-OVA-primed mice and varying concentrations of
TNRcollagen IV (only the optimal concentration of 0.05 jig/ml is shown) in the presence
or absence of 1 Pg/ml purified (rat IgGl) mAb, 111111, or mAb35 (isotype-matched control
antibody) . Serial dilutions of 6 d supernatants were incubated on TNP-BSA coated plates,
followed by the addition of biotinylated andisotype reagents, avidin-peroxidase, and finally
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substrate buffer. Monoclonal antiTNP isotype controls were used to establish the specificity
of the ELISA.
Analysis ofLymph Node CD4' TCell BlastsforIL4, IL2, andIFN-y mRNA by In Situ Hybrid-
ization. Mice were immunized as above and lymph node cells cultured with 25 ,ug/ml col-
lagen IV as described for Fig. 1. After 48 h cells were fractionated into CD4' T cells as above
and blast CD4' T cells were obtained from the interface of 50-607o Percoll (Pharmacia Fine
Chemicals, Uppsala, Sweden) by centrifugation. The procedure used for in situ hybridiza-
tion has been described previously (6); >400 cells contained in >5 fields ofview were counted
for each slide under x 1,000 magnification. Background hybridization was determined with
sense-strand probes.
Results and Discussion
Both humoral and cell-mediated protective immune responses are driven by acti-
vated CD4 + T cells. While cloned T cell lines differ in their functional capabilities,
it is of interest to determine if similar functional specialization exists in normal
CD4 + T cells. Previous studies of this question have examined susceptibility and
resistance of mice to chronic infection with Letshmania major (7, 8); antibodies to
cell surface molecules (9, 10); lectin binding (11); or cytokines produced by single
CD4 + T cells (6). While these studies suggest that subsets of CD4 + T cells similar
to those derived by cloned lines exist in vivo, no understanding of the mechanism
of selecting distinct functional effects or subsets has been obtained. In this report,
we examine the CD4' T cell cytokine production and helper activity during a re-
sponse to type IV human collagen (collagen IV), where it has been observed that
mice expressing the MHC class II gene product I-AS display strong lymph node
antigen-specific T cell proliferation in the absence of significant antibody produc-
tion, while all other genotypes tested lacked proliferative responses but produced
abundant antigen-specific antibody (5). Previous studies of the immune response
to collagen IV did not examine purified CD4' T cells, leaving open the possibility
that the differences observed reflected inhibition of responses by other cell types.
We therefore examined the responses of purified CD4' T cells from mice of
different MHC genotypes for the ability to proliferate in response to collagen IV
(Fig. 1) and to help B cells produce antiTNP antibody in response to TNP-collagen-
IV (Fig. 2 a). As shown, CD4' T cells from mice expressing I-A$ (here, A.SW)
proliferate in response to low doses of collagen IV, while CD4' T cells from mice
expressing I-Ab (here, the congenic strain A.BY) do not respond even to high doses
of collagen IV. This difference is antigen specific, since CD4' T cells from both
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FIGURE 1.
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Lymph node CD4' T cell
proliferative response to human col-
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lagen IV CD4' T cells from I-Aa-
and I-Ab-primed congenic strains
were analyzed for recall proliferation
to either collagen IV or 5wg/ml KLH
in vitro. Error bars represent the SD
oftriplicate wells; background prolifer-
ation (no antigen) was <5,000 cpm
and is subtracted from these values.
Representative data are shown. In sep-
arate experiments, I-A' proliferative
1
￿
10
￿
100
￿
KLH
￿
responses to collagen IV were consis-
TNP-COLLAGEN IV (IIGIYL)
￿
tently 3 a log higher than I-Ab.
t A.BY
150 + A.SW ISO.
X
100
100
a
o.
U
0strains respond strongly to KLH (Fig. 1) and to PPD (5; data not shown). By con-
trast, CD4' T cells from I-A9 mice do not help effectively for an IgG antiTNP an-
tibody response to TNP;collagen IV, while CD4' T cells from I-A' give very po-
tent IgG antiTNP antibody responses that are dominated by IgG1 antibodies (Fig.
2 a). This difference in the secretion of IgG1 antiTNP antibody was observed at
all TNP-collagen concentrations tested (datanot shown). Sincethe secretion ofIgG1
has been shown to be influenced by IL-4 (12, 13), it was important to determine
ifthe IgG1 response to TNRcollagen IV required IL-4 production by T cells from
I-Ab mice. As is shown in Fig. 2 b, the mAb 111311, which is specific for murine IL-
4, significantly and specificallyblocks the synthesis ofIgGI antiTNP in this system.
Thus, IL-4 production appears to be coupled to IgG1 antibody production in this
system.
To further examine whether the dichotomy in responses to collagen IV seen be-
tween I-A- and I-Ab mice reflected selective activation ofTh-l-like or Th2-like CD4'
T cells, respectively, CD4' T cells from immunized mice were restimulated with
collagen IV in vitro, and the responding T cell blasts were assayed for IL-4, IL-2,
and IFN-y expression by in situ hybridization. These cytokines are selectively ex-
pressed by Th2 (IL-4 producing) and Thl (IL-2/IFN-y producing) subsets ofCD4'
T cell clones (4). It can be seen (Fig. 3) that the proliferative response to collagen
IV in I-A' mice is accompanied by the expression ofIFN-y (Fig. 3 b) and IL-2 (Fig.
3 a) mRNA, but not expression ofIL-4(Fig. 3 c) mRNA(background hybridization
was negligible; data not shown). By contrast, the response to collagen IV by T cells
from I-Ab mice is accompanied by the expression of IL-4 mRNA but not IFN-y
mRNA. These results have been confirmed by bioassays ofsupernatants from these
and replicate cell cultures using cytokine-responsive Tcell lines and specific mAbs
to measure individual cytokines. We have consistently observed IFN-y only in I-AS
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FIGURE 2.
￿
Secondary collagen IV-induced
antiTNP antibody responses in vitro. (a) In
vitro TNP-specific IgG antibody responses.
CD4' T cells from collagen-primed mice
were analyzed for their ability to induce anti-
TNP antibody secretion from TNP-primed
B cells in the presence of TNRcollagen IV
(b) Anti-IL-4 inhibition ofTNP-specific IgGI
antibody responses. Results are expressed as
the reciprocal dilution giving an absorbance
of 0.50 at 492 nm.2138
￿
MURRAY ET AL.
￿
BRIEF DEFINITIVE REPORT
cell culture supernatants, IL-2 at low levels in I-A' and high levels in I-A' superna-
tants, and IL-4 when detected only in I-A' culture supernatants (data not shown).
Thus, the induced cytokine response ofnormal CD4` T cells to this antigen is de-
termined by the MHC genotype of the mouse.
The present experiments confirm earlier studies in other experimental systems
that functionally distinct sets ofCD4+ T cells arise selectively in an in vivo immune
response(7, 8, 14). The selective activation ofIL-4-producing cells in strains ofmice
that also produce antibody to collagen IV, and the fact that IL-4 production was
not detected in strains of mice that do not produce specific antibody, support our
previous observationswith Th2 cloned lines(1)suggesting thatIL-4production corre-
lates with helper function in specific antibody responses.
Whether a subdivision ofCD4+ Tcells into Thl and Th2 cells occurs before or
as a result ofantigenic stimulation is not yet clear. It has recently been suggested
that IL-4-producing cells are a consequence of memory responses, i.e., secondary
stimulation, whereas IL-2 producers dominate primary immune responses (9, 15,
16). The present results argue against a simple sequential mechanism, as we ob-
served strong antigen-specific recall T cell proliferative responses that were domi-
nated by IL-2/IFN-y-producing CD4+ Tcells. Rather, the differential activation
ofantigen-specific Thl-likeandTh2-like cellsinmice ofdistinctclassII MHC genotype
strongly suggests that events involved in antigen presentation per se contribute to
the selective activation of a particular subset of T cell.
There are three possible mechanisms by which class II MHC genotype might
control the subset of CD4+ T cells activated during a specific immune response,
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FIGURE 3.
￿
Lymphokine mRNA expression by collagen
IV-primed CD4` T cells. Steady-state mRNA of IL-2 (a),
IFN--y (b), and IL-4 (c) was measured by in situ hybridiza-
tion with ribo probes prepared from lymphokine-specific
cDNA. Blast cells were obtained as described in Materials
and Methods from collagen IV-primed I-A' and I-Ab con-
genic mice and compared for lymphokine mRNA. The fre-
quenciesofpositive cells recoveredfrom the totallymph node
cell populations were similar, i.e., 1.7% (A.BY) and 1.6%
(ASW), and indicate frequencies similar to those reported
for antigen-stimulated IL-2- andIL-4-producing T cells as
analyzed by limiting dilution analysis (16).
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and each applies equally to any of several models of CD4' subset differentiation.
Iftheeffectsobservedreflect the bindingofdifferentpeptides bydifferentI-Aalleles,
then this implies that T cells ofdifferent functional capabilities also differ in their
TCR repertoire. This conclusion is incompatible with optimal functioning ofim-
mune surveillance, sincethere is no a priori mechanism fordeterminingifapartic-
ular epitopewill be expressed on an intracellular or extracellularbacterium. How-
ever, in single cases like collagen IV, this mechanism could operate. Ligand density
could also be controlled by MHC genotype, whether the same ordifferent peptides
are presented. It is possible the CD4' T cells of different functions are responsive
todifferentdensitiesofligand, orthat ligand densitydetermines the functional matu-
ration ofa CD4' cell. Finally, all Tcell activation appears to require both ligand/
receptor interactionsandaccessory cell-derivedsecond signals. IL-2-producing Thl
and IL-4-producing Th2 cellsdiffer in this requirement, andevidence from in vivo
studies are also consistentwith this proposal. Class II MHC genotype couldcontrol
the accessory cell used for priming. For instance, ifa peptide binds poorly to class
II MHC, then only cells internalizing large amounts ofantigen could present this
ligand; antigen-specific B cells, known to be required for priming proliferating but
not helper Tcells, are very efficient in this regard. By contrast, ifa class II MHC
product binds peptide well, then the small amounts ofantigen apparently taken up
by most macrophages could be effectively presented. Data from chimeric chickens
(17) and transgenic mice (Flavell, R., personal communication) both suggest that
priming ofT cells able to provide specific help to B cells requires macrophage pre-
sentationofantigen/MHC complexes. Finally, Thl clones arespecifically inhibited
by high concentrations ofantigen (18), as wouldbe achieved on B cells internalizing
largeamounts ofaproteinwhose peptides bindwelltoclass II MHC. Thus, achieving
thecorrectligand densityonasuitableAPCmaybethe critical determinantofeffector
cell activation, and this could be affected by MHC class II genotype.
In conclusion, our studies demonstrate that class II MHC genotype can control
whether Tcells responding toa given antigenmake IL-2 andIFN-y, orIL-4. There
are several mechanisms that can explain this result. The critical issue now is to de-
termine which ofthem is/are correct, and then to determine at what stage in CD4'
T cell development this functional specialization occurs.
Summary
The present results demonstrate that CD4' Tcells activated in the primary in
vivo response to antigen produce distinct patterns ofcytokinesdepending upon the
MHCclass IIhaplotype ofthe respondingmice. I-As mice were found to selectively
activate IL-2/IFN-y-producing CD4' Tcells, whereas I-Ab mice exhibited selec-
tive activation of IL-4-producing CD4' T cells in response to collagen IV. The
effector response phenotype was found to correlate with the cytokine phenotype of
CD4' T cells activated in vivo; IL-2/17N-y-producing cells giving rise to prolifer-
ative(cell-mediated) responses, IL-4-producing cells leadingto secondary IgG(hu-
moral) responses. Together the data support the notion that the outcome ofa given
immune response (e.g., protection vs. onset, tolerance vs. autoimmunity) may be
determined in part by the type of CD4` T cells initially activated by antigen.
Moreover, thepresent experiments demonstrate forthe first timethatpolymorphism2140
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in class II MHC can determine such selective activation ofdifferent cytokine-producing
CD4+ T cell phenotypes.
Receivedfor publication 1 August 1989 and in revisedform 18 September 1989.
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